Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel with Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
NCT03768414Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel in biliary tract cancer (BTC), sponsored by SWOG Cancer Research Network. Started Feb 2019; status: completed.
02
Drugs
paclitaxel
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT03768414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03768414.